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Abstract
The integration of molecular and cell biology with materials science has led to strategies to 
improve the interface between dental implants with the surrounding soft and hard tissues in order 
to replace missing teeth and restore mastication. More than 3 million implants have been placed in 
the US alone and this number is rising by 500,000/year. Peri-implantitis, an inflammatory 
response to oral pathogens growing on the implant surface threatens to reduce service life leading 
to eventual implant failure, and such an outcome will have adverse impact on public health and 
create significant health care costs. Here we report a predictive approach to peptide design, which 
enabled us to engineer a bifunctional peptide to combat bacterial colonization and biofilm 
formation, reducing the adverse host inflammatory immune response that destroys the tissue 
surrounding implants and shortens their lifespans. This bifunctional peptide contains a titanium-
binding domain that recognizes and binds with high affinity to titanium implant surfaces, fused 
through a rigid spacer domain with an antimicrobial domain. By varying the antimicrobial peptide 
domain, we were able to predict the properties of the resulting bifunctional peptides in their 
entirety by analyzing the sequence-structure-function relationship. These bifunctional peptides 
achieve: 1) nearly 100% surface coverage within minutes, a timeframe suitable for their clinical 
application to existing implants; 2) nearly 100% binding to a titanium surface even in the presence 
of contaminating serum protein; 3) durability to brushing with a commercially available electric 
toothbrush; and 4) retention of antimicrobial activity on the implant surface following bacterial 
challenge. A bifunctional peptide film can be applied to both new implants and/or repeatedly 
applied to previously placed implants to control bacterial colonization mitigating peri-implant 
disease that threatens dental implant longevity.
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INTRODUCTION
There is a continuing need to improve patient treatment to ensure the longevity of the 
therapeutic advantages offered by titanium dental implants 1–8. The creative fusion of 
molecular and cell biology with materials science and engineering has resulted in improved 
understanding of implant-tissue interfaces 9. These advances have been translated clinically 
to improve oral and systemic health through the replacement of diseased teeth by titanium 
dental implants, among numerous examples 10–12. Titanium and its alloys have the 
requisite toughness needed to resist the repeated loading that occurs with food mastication. 
Titanium is biocompatible, and more importantly, inherently promotes its own integration 
into host bone by activating the Wnt/integrin signaling pathway for osteogenesis 13.
In recent years, increased reliance on dental implants to restore missing teeth has resulted in 
a concomitant rise in the prevalence of peri-implant disease, a host-mediated immune 
response to bacteria which can shorten implant life and culminate in the loss of the implant 
14–15. A growing consensus suggests that peri-implant disease is similar to periodontal 
disease: bacterial plaque accumulation and microbiome dysbiogenesis trigger a host immune 
inflammatory response that destroys soft- and hard-peri-implant tissues 16–18. Within 
weeks after implant placement, a biofilm develops consisting of the typical subgingival 
bacterial species, including keystone periodontal pathogens such as A. 
actinomycetemcomitans, P. gingivalis, T. forsythia, T. denticola, and P. intermedia 19–21. 
Dysbiosis shifts the relative abundance of commensal species to pathogens. For many 
patients, this shift induces the host to mount an inflammatory response leading to peri-
implant disease, starting with peri-implant mucositis and progressing to peri-implantitis, 
which is accompanied by dramatic bone loss that can necessitate implant removal 22. A 
treatment protocol that can slow and/or prevent bacterial infection may help to mitigate the 
host immune response and slow peri-implant disease progression.
The incidence of peri-implantitis is reported to be as high as 14.5% after 9 years of service 
although clinically significant, non-linear loss of bone support around the implants may be 
present as early as after 3 years after placement in more than 80% of patients 23. With over 
3 million implants placed in the US alone and growing by 500,000 implants/year 7, a 
reduced service life ending in implant failure will adversely impact public health, trigger 
increased health care costs and precipitate a loss of public confidence in the dental 
profession. Furthermore, this outcome may dissuade many patients to avoid this therapy who 
would benefit from the health benefits of implants. Currently, the goal of implant disease 
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treatment is to control bacterial infection through mechanical debridement and bacterial 
plaque control in order to mitigate the host immune response, in order to slow disease 
progression 24. However, debridement, which is often performed with titanium brushes 25 
results in implant surface damage and loss of biocompatibility. This hastens inevitable apical 
movement of the implant-supporting tissues and worsens the loss of supporting hard and soft 
tissue.
An additional challenge associated with prevention of implant infection is the increased 
incidence of bacterial resistance, which represents a major public health concern 26–29. 
Novel antibacterial agents and strategies are needed to ensure future therapeutic efficacy 30. 
While systemic antibiotics can treat infections that result from non-resistant bacteria, the 
peri-implant environment poses many challenges. Implant surfaces are susceptible to biofilm 
development as bacteria attach to the surface and synthesize an extracellular biofilm matrix 
31. An estimated 80% of human infections are associated with biofilms 32. Biofilms 
respond differently to antibiotics than planktonic bacteria and are difficult for antibiotics to 
penetrate 31, 33. Poor antibiotic penetration into biofilms results in subtherapeutic antibiotic 
concentrations and increases the likelihood of developing antibiotic resistance 34. 
Preventing the attachment and killing of planktonic bacteria to the implant surface, while 
killing them via antimicrobial agents that do not lead to the development of resistance 
represents a novel strategy for reducing biofilm formation and preventing persistent infection 
that leads to implant failure 35–36.
One approach to addressing bacterial resistance is the use of antimicrobial peptides (AMPs). 
AMPs are natural antimicrobials that form part of the innate immune defense peptides of 
both invertebrates and vertebrates. Most AMPs contain fewer than 50 amino acids and more 
than 2800 AMPs have been discovered from natural resources 29. Integration of computer-
assisted peptide design methods has increased the number of in silico designed antimicrobial 
peptides 37–39. The mechanisms of AMP action on bacteria includes membrane 
perturbation, disruption and/or translocation affecting diverse physiological events such as 
cell wall biosynthesis, pore formation, and cell division, as well as non-membrane-based 
pathways 37, 40. The mechanism for GL13K action on bacterial membranes involves 
localized removal of lipid from the membrane through peptide induced micellization. The 
mechanism for action of AMPA is not yet fully explored, it is also considered to have its 
action through membrane permeation41–42. Furthermore, their antimicrobial affects can 
mitigate biofilm formation when used alone or in combination with other AMPs, or even 
with antibiotics, to achieve the desired antimicrobial effect and preserve the health of the 
host tissues without triggering resistance.
Systemic delivery of AMPs has been a major limiting factor in their wider use as 
therapeutics because a high AMP concentrations is required to achieve effective 
antimicrobial activity and such levels can potentially result in in vivo damage to host cells 
43. Local delivery of AMPs may overcome this challenge by reducing and focusing the 
required therapeutic concentration and thereby decrease the potential for deleterious effects 
on eukaryotic cells 43. The advantages of delivering AMPs locally have been explored using 
a variety of methods for their retention on implant surfaces, including physical adsorption 
and chemical immobilization strategies. Chemical immobilization strategies include 
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covalently attaching AMPs to the implant surfaces using silane-, catechol- and phosphate-
groups 44–47. Structural constraints introduced to the AMP during covalent coupling are 
known to limit antimicrobial activity, more so, the covalent coupling procedure can only be 
performed prior to implantation, as they are generally performed under harsh conditions 
which prevents their intraoral application. To this point, investigators recently demonstrated 
that amphipathic GL13K antimicrobial peptide can be used to coat dentin to resist recurrent 
caries around resin bonded dental restorations 48–49. Combinatorial screening of peptide 
sequences with affinity for various materials has identified hundreds of peptides with the 
ability to self-assemble on metal-, metal oxide-, mineral- and polymer-surfaces 50–54. As 
the number of the biocombinatorially selected peptides increased, computational methods 
have provided an understanding for the peptide-solid materials interactions, as well as for 
their self-assembly and molecular recognition mechanism(s) on nanostructured materials 
including metals, metal oxides, ceramics and others 55–56. By merging biocombinatorial 
and computationally methods, we have developed high affinity inorganic binding peptides 
for titanium and titanium alloys. Furthermore, we have engineered these peptides into 
bifunctional peptide molecules that incorporate biologically instructive signaling functions 
in order to create novel, bioactive biomaterial interfaces 57–61. We demonstrated that 
titanium binding peptides (TiBP) can be used to design a biomimetic interface for enhancing 
bioactivity in osteoblast and fibroblast cells when coupled with RGD peptides 62. We have 
further demonstrated that TiBP is an effective anchor for AMPs on implant surfaces, serving 
to localize the molecule effectively for repeated intraoral applications 63. When a TiBP 
anchor was combined with a Wnt signaling peptide 64–65, the resulting bifunctional peptide 
produced a peptide film on implant surfaces that led to enhanced osteogenesis in human 
stem cells, consistent with directed bone regenerative capacity 11. We next combined the 
TiBP with antimicrobial peptides and demonstrated their effective use against E. coli, S. 
epidermis and S. mutant strains 66 67. While our earlier studies utilized a simple flexible 
spacer of amino acids, e.g., “GGG”, to combine two distinctive AMPs, we have now 
analyzed sequence-structure-function relationships for optimal design of the spacer. By 
computationally studying the Dictionary of Protein Secondary Structure (DSSP) features 
and observed patterns, we proposed secondary structure “rules” to enhance antimicrobial 
activity of bifunctional peptides. By designing a rigid and longer amino acid spacer domain, 
“GSGGG”, between the TiBP and the AMP domains, we significantly improved the 
antibacterial efficacy against S. epidermis bacteria 68. We demonstrated the TiBP as an 
effective anchor for the AMPs on implant surfaces serving to localize the molecule 
effectively for repeated intraoral applications 63.
Here, we report a novel antimicrobial medicinal approach to slowing or halting the 
progression of peri-implant disease by furthering the design of bifunctional peptides that 
deliver a local antimicrobial peptide. This film can be applied in two minutes and can be 
repeated at follow up appointments 63. The renewable effects of the bifunctional peptides 
upon successive reapplication were evaluated on bacteria-fouled and -cleaned dental implant 
surfaces, mimicking the re-treatment of implants affected by peri-implant disease in a dental 
office 63. We systematically studied the sequence-structure-function relationships of two 
bifunctional peptides that incorporated structurally distinctive antimicrobial peptides 
combined with the same anchoring domain using a newly developed longer, more rigid 
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peptide spacer. Our secondary structure prediction suggested that greater helical content 
could improve antimicrobial activity while preserving the intrinsically disordered behavior 
of TiBP for effective surface binding. The resulting bifunctional peptides were evaluated for 
their suitability for clinical deployment using tests of peptide binding, stability, antimicrobial 
function and durability in vitro on titanium implant discs (see “Schematic”). Our 
computational predictions were merged with experimental structural analyses and showed 
enhanced design of bifunctional peptides with the best candidate molecules outperforming 
other peptides in promoting antimicrobial film activity. Overall, we demonstrate that our 
engineered small bifunctional peptide selectively binds to titanium/titanium alloy implant 
surfaces to deliver an antimicrobial peptide film in as little as two minutes. This non-surgical 
approach has the potential to improve oral health by controlling microbial dysbiogenesis and 
reducing peri-implant disease progression. This approach could be more widely beneficial 
for the design of a range of bioactive biomaterials interfaces that could for the basis for next 
generation therapeutics.
MATERIALS AND METHODS
Peptide Synthesis, Purification, and FITC-derivatization
Peptides were synthesized by standard solid phase peptide synthesis technique using Fmoc 
chemistries and Wang resins (AAPPTec Focus XC solid phase peptide synthesizer, 
Louisville, KY). Fmoc protecting groups were removed by 20% piperidine in 
dimethylformamide (DMF). Following deprotection, piperidine was removed by DMF and 
the samples were solubilized in DMF at a concentration of 0.2M and added in 7-fold excess. 
The amino acids were activated with 0.4M O-benzotriazole-N,N,N’,N’-tetramethyl-
uronium-hexafluoro-phosphate (HBTU) and 1M 4-methyl morpholine (NMM) in DMF. 
Reactions were performed with mechanical mixing under nitrogen gas. Resin-bound 
peptides were dried with ethanol and cleaved using a cleavage cocktail. Reagent K (TFA/
thioanisole/phenol/ethanedithiol at a ratio of 87.5:5:5:2.5) was used to deprotect side-chain 
and peptides were precipitated with cold ether. The crude peptides were purified using 
reverse phase-HPLC to greater than 98% purity, lyophilized and stored at −20°C.
Fluorescein 5(6)-isothiocyanate (FITC) was used to fluorescently derivatize bifunctional 
peptides on their free C’-termini for experiments requiring visualization of bifunctional 
peptide molecules bound to the surface of titanium implant discs.
Peptide Property Calculations
Physicochemical data on the peptides including molecular weight, isoelectric point, charge 
and GRand AVerage of hydropathY (GRAVY) scores were obtained using the ExPasy 
ProtPram Server 69. Hydrophobicity was evaluated by the antimicrobial peptide database 
(APD3) 38.
Peptide CD Data Collection and Secondary Structure Prediction
Secondary structure estimation was accomplished using a Jasco J-810 circular dichroism 
(CD) spectrophotometer. Solutions of 40μM peptide in 100mM Tris-HCL buffer with 
varying volumes of 2,2,2-trifluoroethanol (TFE) were prepared for CD analysis. A minimum 
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of 8 scans over wavenumber 190–260nm with a scan rate of 0.5 nm/min were collected on a 
calibrated spectrophotometer and averaged. The background was subtracted, and the spectra 
smoothed using the Savitzky-Golay algorithm. The resulting CD spectra were deconvoluted 
using the BeStSel web server for accurate prediction of protein secondary structure and 
folding 70.
Predicted secondary structure contents for helical (α, 310 and π-helix), beta (β-bridge, 
bonded turn), and irregular (bend and loop) features were determined using the Chou-
Fasman algorithm. The Chou-Fasman algorithm was applied for each bifunctional peptide 
after uploading their CD spectra and amino acid sequences using the online server available 
through the CD Analysis and Plotting Tool (CAPITO) 71.
Peptide Structure Analysis
The de novo 3D structural modeling algorithm, PEP-FOLD 3.5, was implemented to 
generate Protein Data Base (PDB) models for a minimum of five of the best predictions for 
each bifunctional peptide sequences 72–73. PEP-FOLD 3.5 was used to generate 3D-
structural conformations of linear peptides. PEP-FOLD 3.5 generates peptide structures by 
assigning one of 27 structural alphabets where fragments of four amino acid residues 
overlap with three residues. The structural alphabet generalizes the secondary structure by 
assigning geometric descriptors created by the Hidden Markov model as described by 
Maupetit, et. al., 74. 3D models were ultimately generated from the fragments using a 
coarse-grained representation and refined by 30,000 Monte-Carlo steps using the PEP-
FOLD 3.5 online service on an average of 200 simulations executed assuming aqueous 
conditions and neutral pH. Once generated, the models were clustered and sorted using 
sOPEP (Optimized Potential for Efficient Structure Prediction) with non-biased modeling.
Similarity among the predicted secondary structure models for the bifunctional peptides was 
compared for each of the constituent domains: titanium binding domain (TiBP), spacer, and 
each of two unique antimicrobial domains using the MatchMaker tool. The individual 
constituent domain structures were superimposed on the corresponding segments of the 
bifunctional peptide structure. The Match-Align tool was used with a 5Å threshold and the 
percent identity or degree of relatedness was recorded.
Backbone rigidity of the bifunctional peptides was predicted using the DynaMine Webserver 
following their amino acid sequence in FASTA format 75. The server segmented the 
sequence and the fragments were used as the input for the DynaMine predictor for the given 
segment length. The predictions for each segment were reassembled to produce a dynamics 
profile from the amino acid sequence.
Protein Data Bank files containing the secondary structure models generated by PEP-FOLD 
3.5 were visualized and further analyzed by the UCSF Chimera program 76. The theoretical 
“footprint” for each bifunctional peptide was calculated using the measure tool in Chimera. 
The footprint was determined by obtaining the distance from the α-carbon of amino acid 
residues to obtain length and width values. These measurements were converted to 
corresponding area and the number of peptide molecules required to saturate a 10 mm disc 
surface area serving as an implant mimic was determined. The number of peptides was 
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converted to a molecular mass required to deliver the corresponding surface coverage to the 
titanium implant disc surface.
A web interface program DichroCalc 77 was used to predict the theoretical circular 
dichroism spectra from secondary structures models predicted with PEP-FOLD 3.5. Spectra 
were requested in ellipticity units [(deg. cm2)/dmol] over wavenumber 190nm to 260nm and 
compared to the corresponding experimentally collected spectra. The Hirst ab initio 
parameter set was used for backbone chromophores.
Titanium Implant Disc Preparation
Coin-shaped titanium implant discs were punched from grade 4 titanium by the USC 
Engineering Shop. The discs were 10mm in diameter and 0.5mm thick, lap-polished and air-
blasted with 180–220 micron titanium dioxide particles. Following manufacturing, the discs 
were cleaned as stated in a published protocol used for producing surfaces optimal for 
osseous integration 4. The protocol included sonication in DI H2O for 5 minutes, ethanol for 
30 seconds, DI H2O for 30 seconds, 40% sodium hydroxide for 10 minutes, washed in DI 
H2O for 5 minutes, 50% nitric acid for 10 minutes followed by rinsing with DI H2O for 5 
minutes. The discs were autoclaved prior to use.
Peptide Binding to Implant Discs
Titanium implant disc functionalization with bifunctional peptides was accomplished by 
incubating 100μL of a specified fold concentration of the theoretical “footprint” 
concentration onto clean, sterile discs for different time periods at 37°C for 2 minutes. 
Following incubation, the discs were transferred to a sterile well in a 24-well plate 
containing 500μL of DI H2O and washed multiple times to remove unbound peptide. The 
discs were transferred to a clean glass microscope slide for imaging using a fluorescent 
microscope. All experiments were repeated a minimum of three times and images were 
recorded at 10X magnification.
Determination of Surface Coverage
A custom MatLab script was developed to determine the percent surface coverage of 
fluorescently labeled bifunctional peptides on the implant disc surface. The color fluorescent 
images were read into MatLab using the imread function. The images were converted to 
black and white and the total number of black and white pixels quantitated. The number of 
white pixels corresponding to the fluorescently labeled peptides, was divided by the total 
number of pixels to determine the percent surface coverage. The theoretical footprint was 
used solely to determine an ab initio concentration for achieving an optimal bifunctional 
peptide interface in a clinically relevant time interval and did not include lateral resolution.
Serum Competition Assay
Serum competition binding assay was completed with 1.0wt%, and 5.0wt% of bovine serum 
albumin (BSA) at selected theoretical “footprint” concentrations of FITC-labeled 
bifunctional peptide. Prior to functionalization of sterile titanium implant discs, a solution of 
BSA and the bifunctional peptide was made in a sterile centrifuge tube. In a sterile 24 well 
plate, 100μL of the BSA/bifunctional peptide solution was pipetted onto a titanium implant 
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disc and incubated at 37°C for 2 minutes. The discs with BSA/bifunctional peptide were 
transferred to a new well containing 500μL sterile deionized water for 1 minute and washed 
to remove unbound peptide. The discs were transferred onto a clean glass microscope slide 
and imaged as previously described 63.
Mechanical Durability Assay
Sterile titanium implant discs were functionalized with FITC-labeled bifunctional peptides 
and brushed using a commercially available electric toothbrush, as previously described 63, 
78–79. Deionized water was applied to the functionalized discs and an electric toothbrush 
with a round head the same size as the implant disc was applied to the disc for 1 minute. A 
100g weight was secured to the toothbrush 10cm from the brush head to ensure consistent 
force during brushing. Following brushing the implant disc was imaged.
Bacteria Culture
Streptococcus mutans bacteria (ATCC 700610) were cultured according to an ATCC 
protocol. Frozen stocks were streak plated on agar and incubated for 24 hours at 37°C in 
atmosphere with 5% CO2. A single bacterial colony was used to inoculate 5mL of Brain 
Heart Infusion (BHI) broth in a sterile 50mL conical tube and incubated overnight in the 
same conditions. Following incubation, 1mL of culture was added to 9mL of fresh media 
and grown to mid-log phase with a final concentration of 105 CFU/mL.
Visualizing Bacteria on Implant Discs
Following the functionalization of titanium discs, they were transferred to a sterile well in a 
24-well plate and 400 μL of S. mutans bacteria at a concentration of 103 CFU/mL was 
added to the wells containing the discs and incubated for 24 hours at 37°C in atmosphere 
with 5% CO2. Following incubation, discs were imaged with a fluorescent microscope to 
visualize FTIC-labeled bifunctional peptides on the disc surface after bacterial challenge. 
The dead bacteria were stained with propidium iodide and imaged using a fluorescent 
microscope. Experiments were repeated in triplicate and images were recorded at 10X 
magnification.
Statistical Analysis
For all experimental groups, values are reported as mean ± standard deviations. One-way 
analysis of variance (ANOVA) was performed to assess statistical significance. Statistical 
significance was set at p<0.05.
RESULTS AND DISCUSSION
We explored the structure-function relationship of bifunctional peptides designed with two 
distinct antimicrobial peptide domains. Each bifunctional peptide molecule incorporated 
three peptide domains: an implant anchoring domain provided by the TiBP, an antimicrobial 
domain provided by the AMP, and a spacer domain to ensure the functionality of each of the 
two other domains when constrained within a single peptide chain. Computationally derived 
rules for predicting performance of antimicrobial bifunctional peptide films and 
experimentally evaluated for antimicrobial activity, extent of film coverage and binding, 
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binding under competition from an interloper contaminant, and mechanical durability within 
clinically relevant parameters needed by dentists to treat peri-implant disease.
Design by Structure Prediction from Amino Acid Sequence
In our earlier work, we identified secondary structure rules that associate greater 
antimicrobial property with α-helix features adopted over 4- and 5-amino acid residues 67. 
Based on this, we screened the CAPITO Webserver provided in the Antimicrobial Peptide 
Database (APD) that contains the cationic AMPs identified with low minimum inhibitory 
concentrations (MIC) based on their percentage of α-helix secondary structure 71. The 
method implemented in CAPITO uses the Chou-Fasman algorithm to analyze the relative 
frequencies of amino acids adopting a specific secondary structure conformation based on 
protein structures previously solved by X-ray crystallography. The secondary structure 
prediction mainly relies on the probability parameters obtained for the occurrence of α-
helix, β-sheet and turns. The Chou-Fasman method is roughly 60% accurate in predicting 
secondary structures compared to 80% accuracy achieved by some of the recent machine 
learning approaches 71; however computationally Chou-Fasman remains a simple and 
efficient method for approximating secondary structure content starting from an amino acid 
sequence. Chou-Fasman was used as an initial estimation tool in developing rules for the 
antimicrobial peptide film property. We identified two AMPs with low MIC: AMPA80, 
comprised of 60% predicted α-helix forming amino acids and GL13K81 containing no 
predicted α-helix forming amino acids (Table 1). The MIC for each AMP is given is 
Supplemental Information Table S1. Titanium binding peptides were selected using phage 
display and characterized for their binding affinity using Quartz Crystal Microbalance 
Spectroscopy (QCM) 62 67. Based upon this earlier work, we selected one of the strong 
titanium binding peptides as a promising candidate for the bifunctional peptide film 62. 
When AMPA was combined with a spacer to the titanium binding peptide (TiBP) domain, 
the α-helix content of the resulting bifunctional TiBP-AMPA increased to 69%. Whereas 
combining TiBP with GL13K resulted in a drastic change to the α-helix content for the 
bifunctional TiBP-GL13K molecule, with α-helix content as low as 50%.
Native chimeric proteins containing multiple functional domains often are separated by 
inter-domain sequences called “spacers” that enable multiple domains to coexist on a single 
polypeptide chain. Inspired by this, we studied different spacer sequences when designing 
the bifunctional peptides described here. The goal of the spacer design was to preserve and 
enhance the function of each of the functional domains within the molecule. We previously 
tested the effects of spacers on the overall bifunctional peptide by testing them with a single 
antimicrobial peptide, AMP1, linked with a strong titanium binding peptide sequence (TiBP) 
62, 66–68. Here, a five-amino-acid spacer, i.e. GSGGG, resulted in drastic improvement of 
the antimicrobial efficacy against S. epidermis, compared to a three amino acid, GGG 
spacer. We therefore elected to combine the TiBP domain to each of the two selected AMPs 
using the GSGGG spacer.
Table 2 provides the physicochemical properties for AMPs and the related bifunctional 
peptide. Both of the AMPs selected are cationic with net positive charge of 5 and 4, 
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respectively for AMPA and GL13K. In contrast, the net charges of the corresponding 
bifunctional peptides, TiBP-AMPA and TiBP-GL13K increased to 8 and 7, respectively.
The Chou-Fasman secondary structure algorithm predicted greater helical content in the 
bifunctional peptides compared to either of the AMP domains in isolation. Further, the 
distribution of secondary structure between the AMPs in isolation compared to the 
bifunctional peptides suggested that the AMPA domain retained a greater percentage of 
secondary structure than GL13K. Thus, we predicted that a “design with AMPA would have 
greater antimicrobial potential than one containing GL13K. We recognize the limitations of 
Chau-Fasman in predicting secondary structure; however, the GL13K α-helix prediction 
differed only by 10% from a recently reported estimate on the secondary structure of GL13K 
using a complementary approach 48–49.
Design by Hydrophobicity and Amphipathicity
Hydrophobicity and amphipathicity are believed to allow the AMP to penetrate a bacterial 
lipid bilayer and disrupt the cell membrane 82–83. Using the Calculate and Predict tool from 
the Antimicrobial Peptide Database (APD), it was determined that TiBP-AMPA has a 
hydrophobic ratio of 30% with 10 hydrophobic residues aligned along the same surface of 
the α-helix. TiBP-GL13K revealed a hydrophobic ratio of 26%, slightly less than that of 
TiBP-AMPA, with only 5 hydrophobic residues aligned on the same surface (Supplemental 
Information Figure 1). This sequence analysis revealed that the majority of the hydrophobic 
amino acids in both bifunctional peptides were located in the AMP region. The TiBP region 
contains only one hydrophobic residue on the C’-terminus of the binding peptide, 
immediately before the spacer. The hydrophobic nature of the bifunctional peptide is 
attributed to the AMP portion, which may increase the likelihood of the AMP interacting 
with the bacterial membrane while the binding domain remains anchored on the implant 
surface. To visually demonstrate this distribution of residues, we generated helical wheels 
using an online tool (http://rzlab.ucr.edu/scripts/wheel/wheel.cgi). The helical wheel 
diagrams represented in Figure 1 show that 10 hydrophobic residues reside on the same 
surface of the α-helix for TiBP-AMPA compared to only 5 for TiBP-GL13K.
Dynamics Prediction in Bifunctional Peptide Design
Next, the dynamics of the peptide backbone were studied to determine the disorder of the 
regions within the whole bifunctional peptide relative to their constitutive binding, spacer, 
and AMP domains. DynaMine, a tool that leverages chemical shift data to make predictions 
about backbone dynamics at the amino acid residue level, was used for this purpose. The 
dynamics of the residues are essential for peptide function, so evaluating the backbone 
dynamics in relation to the bifunctional peptide function is important in considering the 
design of these peptides 75. Given a protein sequence, DynaMine predicts backbone 
flexibility at the level of amino acid residue in the form of backbone N-H S2 order 
parameter values. These S2 values represent how restricted the movement of the atomic 
bond vector is with respect to the molecular reference frame. The results from the DynaMine 
analysis are depicted in Figure 2.
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The more hydrophilic amino acids located in the AMP domain of the bifunctional peptide 
correspond to the more ordered region of the bifunctional peptide. The Gly and Ser residues 
comprising the spacer region are known to be more disordered serving to promote the 
propensity for a more dynamic backbone that improves overall function of the tethered 
molecule, namely binding to the implant surface while presenting an active antimicrobial 
domain. This is important for dental implants as the accumulation of a biofilm on the 
implant is believed to lead to an adverse host immune response to the bacterial antigens, 
resulting in host directed inflammatory destruction of soft and hard tissues surrounding the 
implant 18, 22, 84–85. Consistent with this interpretation, the binding domain for the 
bifunctional peptides showed the least variation in order. Intrinsically disordered proteins 
(IDPs) function in a wide spectrum of biological situations due to their ability to adapt their 
structure by adopting a conformation over a small number of amino acid residues 75, 86–88. 
Thus, it would be expected that the dynamics of the binding domain may resemble the range 
of conformational structure observed within IDPs.
Secondary Structure Modeling and Analysis
A more in depth secondary structure prediction was accomplished by developing structural 
models from the amino acid sequences using PEP-FOLD 3.5 89. Secondary structure 
models generated for the individual domains and the bifunctional peptide appear in Figure 3. 
Secondary structural analysis of the antimicrobial peptide domains, AMPA and GL13K, 
revealed that the AMPA domain is composed of two short α-helixes joined by a turn while 
GL13K is composed of one short α -helix. The Chou-Fasman analysis did not identify 
helicity exclusive to the GL13K domain, although helicity was predicted for the bifunctional 
peptide, TiBP-GL13K.
The mechanism by which amphipathic α-helical AMPs kill bacteria may involve their 
creation of trans-bilayer pores which serve to disrupt the bacterial membrane by separating 
the polar from the non-polar parts90. Thus, we predicted TiBP-AMPA would have greater 
antimicrobial activity than TiBP-GL13K due to the greater number of membrane-disrupting 
helical features present in AMPA (two features) compared to GL13K (one feature).
Using Chimera, the PDB file could be compared using the MatchMaker tool and the 
structure models superimposed 91. Similarity among each of the individual functional 
domains was evaluated by superimposing the structural model for the AMP and TiBP 
domain alone on the corresponding portion of the bifunctional peptide. The superimposed 
structures were further studied to determine the percent identity or the degree of relatedness. 
This was useful in determining the preservation of the TiBP domain and each antimicrobial 
domain when linked by the spacer in the whole bifunctional peptide. This analysis revealed 
that 91.7% of the TiBP domain identity was preserved when combined with either AMPA or 
GL13K through the GSGGG spacer. The GL13K domain retained 92.3% identity, while the 
AMPA domain retained only 60% identity. This suggests that most of the secondary 
structure of the TiBP and GL13K domain are preserved by the GSGGG spacer, while further 
engineering of the spacer could improve the antimicrobial activity of TiBP-AMPA. 
Preservation of the TiBP domain is postulated to be critical for binding to the implant 
surface in the presence of competing proteins while contributing to the durability of the 
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bifunctional peptide in the oral environment both of which are an essential property for 
effective clinical deployment..
Experimental Determination of Secondary Structure
Next, secondary structure of the bifunctional peptide was experimentally determined using 
CD spectroscopy in an aqueous environment with increasing concentrations of TFE to 
mimic peptide film behavior. Theoretical spectra were determined using DichroCalc 77 from 
the PDB files generated from the secondary structure models. Secondary structures of the 
bifunctional peptides were evaluated experimentally using CD spectroscopy in an aqueous 
environment. The presence of ordered or disordered conformational state was assayed for 
each bifunctional peptide. We next evaluated the folding propensity of the peptide sequences 
in the presence of increasing TFE concentration. TFE is used as a structure stabilizing 
solvent to mimic the restricted mobility of the peptides due to inherited function of the 
bifunctional peptide. As the bifunctional peptide interacts with the titanium surface through 
its anchoring domain it also interacts with the bacterial membrane via the antimicrobial 
domain. Theoretical spectra were determined using DichroCalc from the PDB files 
generated from the secondary structure models 90. Analyses performed by the Dynamine 
program for dynamic behavior of the TiBP domain suggest the TiBP behaves as an 
intrinsically disordered peptide. While these structural states are representatives of the 
peptide in aqueous environments, circular dichroism data supported this behavior. In the 
absence of the TFE, both of the peptides exhibited a strong negative ellipticity band around 
198nm representing the pi-pi* transition. This is a characteristic band for random coil 
conformation which is in equilibrium with other secondary structures. Based upon our prior 
TiBP related work, we conclude that the titanium binding features of the bifunctional 
peptide was preserved 66. Overall, addition of TFE to each peptide resulted in reduced 
intensity of the pi-pi* transition ellipticity band and an observed ~10 nm red shift in 
absorption wavelength. These results suggest a shift in secondary structure population and 
both peptides undergoing some degree of conformational reordering in the presence of TFE. 
Relating such transitions to the bifunctionality of the peptide may provide insights for 
rational design for bioactive interactions at the interfaces by the peptide.
The CD spectra were deconvoluted using Beta Sheet Selection (BeStSel), a method for 
secondary structure determination from CD spectra 70. BeStSel links the CD spectra 
structural findings to the computational Dictionary of Protein Secondary Structure (DSSP) 
patterns 92. Our previously described “Rule Induction” method also relied on DSSP 
structure patterns and identified a pattern of 4- and 5- amino acid α-helix structures as being 
linked to antimicrobial activity in bifunctional peptides 67–68. The BeStSel tool allows for 
deconvolution of experimental CD spectra into the structural feature patterns that are used to 
inform the “Rule Induction” method. Both bifunctional peptides were found to switch their 
conformation from an unordered state in aqueous buffers to their functionally relevant α-
helical conformation in the presence of TFE. The theoretical CD spectra determined from 
the PDB model files more closely represented the 90% TFE environment. This suggests that 
the computational structural predictions are more accurate for environments similar to the 
conditions in which the peptides act as a film. The results from the deconvolution using 
BeStSel for TiBP-AMPA and TiBP-GL13K are depicted in Figure 4.
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Theoretical Surface Coverage Determination
The concentration of bifunctional peptides theoretical needed to provide 100% surface 
coverage when applied onto an implant-mimicking titanium disc surface was estimated by 
measuring the dimensions of the binding peptide domain to obtain a theoretical “footprint” 
area. The resulting area was used to determine the concentration of peptide molecules 
required to cover a 10 mm diameter titanium implant disc (Table 3). One limitation of the 
theoretical surface coverage concentration calculation is that the surface is assumed to be 
smooth; however, the surface roughness produced by blasting an implant with titanium 
dioxide to promote osseous integration would result in a greater surface area than what 
would be calculated. This limitation was overcome by using a multiple of the theoretical 
binding concentration, up to 6-times (6X), to achieve near 100% surface coverage after a 
two-minutes binding period. We focused on minimizing the time required to achieve 
complete surface functionalization by the bifunctional peptide because this will be important 
in translating this technology to a clinical application. The two-minute binding time frame 
represents a reasonable working time for application of the bifunctional peptide film in a 
clinical environment.
Evaluation of Binding, Stability and Durability
The theoretical footprint concentration of each bifunctional peptide with a multiple of the 
binding concentration up to 6X was determined to result in near 100% surface coverage after 
incubation with a titanium implant disc for only two minutes at 37°C. Following incubation, 
the discs were washed to remove unbound or non-specifically bound peptide from the 
surface prior to imaging with a fluorescent microscope. The fluorescent images were then 
analyzed using a MATLAB script to determine the percentage of the implant disc covered by 
the bifunctional peptides. The initial binding for TiBP-AMPA resulted in 99% surface 
coverage after two minutes compared to 96% for TiBP-GL13K. This indicates that in a 
clinically achievable application, the bifunctional peptide are able to form an antibacterial 
film with near complete coverage of the implant surface. Representative fluorescent images 
for each bifunctional peptide are depicted in Figure 5, while the chart indicates the mean 
with standard deviation error bars for three replicate experiments.
The bifunctional peptide film could be applied to a new dental implant prior to implantation 
and subsequently during recall appointments for treatment to previously placed implants. 
Recently we demonstrated in vitro, a bifunctional peptide that retained ability to bind to the 
implant surface after overnight incubation in vitro after bacterial fouling and cleaning using 
a commercially available electric toothbrush 68. The re-binding of the bifunctional peptide 
to a fouled and cleaned surface represents the feasibility of applying this technology to 
existing implants at recall appointments where the bifunctional peptide can be reapplied. 
However, when rebinding the bifunctional peptide in the oral environment, the peptide will 
compete for the implant surface with serum and saliva proteins, even after the implant is 
cleaned using standard dental practices. Thus, the ability of the peptide film to functionalize 
the implant surface in the presence of serum proteins was determined by pre-mixing the 
peptide with varying concentrations of bovine serum albumin (BSA) followed by incubating 
the mixture on the titanium disc for 2 minutes at 37°C. The results of the competitive 
binding of the bifunctional peptide in the presence of 0.01% BSA are depicted in Figure 5. 
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TiBP-AMPA achieved 80% surface coverage while TiBP-GL13K achieved 73% surface 
coverage. There was no statistical difference between the coverage achieved by the two 
bifunctional peptides coverage in competition with BSA.
The durability of the bifunctional peptide films was evaluated by brushing the functionalized 
implant discs with a commercially available electric toothbrush with a round head slightly 
larger than the implant disc for one minute. The presence of bifunctional peptides was 
determined by fluorescently imaging the discs with FITC-labeled peptides before and after 
brushing. The durability of the TiBP-AMPA peptide film was significantly (p < 0.05) greater 
than that of the TiBP-GL13K peptide film. For TiBP-AMPA, 75% of the bifunctional 
peptide coating was retained compared to 27% for TiBP-GL13K (Figure 5).
Bifunctional Activities of the Designed Peptides
The binding and antimicrobial domain activities were evaluated by challenging the 
bifunctional peptide film applied to titanium implant discs with S. mutans bacteria for 24 
hours. The FITC-labeled bifunctional peptides were visualized on the disc surface following 
24 hours of bacterial challenge using a fluorescent microscope and the surface coverage was 
determined using MATLAB. The surface coverage was 84% for TiBP-AMPA and 60% for 
TiBP-GL13K. Representative fluorescent images of FITC-labeled bifunctional peptide on 
the implant disc and quantification of the percent surface coverage of three replicate 
experiments are contained in Figure 6.
The percentage of α-helical secondary structure computationally predicted by the Chou-
Fasman method, the secondary structure modeling and the experimental determination of 
secondary structure using CD supported our design prediction that TiBP-AMPA would 
outperform TiBP-GL13K in promotion of an antibacterial implant interface. We relied upon 
the previously established “rule” method 39 for the design of the bifunctional peptides in 
this manuscript took into the structural composition of the entire bifunctional peptide, not 
just the binding- or antimicrobial-domains. The rule method was trained on antimicrobial 
function with experimentally determined antimicrobial functions as the to identify secondary 
structural features in bifunctional peptides that promote formation of an effective interface 
for the prevention of implant associated infection.
The antimicrobial functional efficacy of TiBP-AMPA compared to TiBP-GL13K supported 
our design prediction. The use of propidium iodide (PI) staining to identify dead bacteria on 
the titanium disc surface showed 46% dead bacteria coverage for TiBP-AMPA, compared to 
10% dead bacteria coverage for TiBP-GL13K. Sterilized bare discs were used as controls 
showed no dead bacteria. Representative fluorescent images and quantification of three 
replicate experiments are depicted in Figure 7.
While one might postulate that this increase in antimicrobial function could due to the 
amount of bifunctional peptide remaining on the surface, e.g. 84% for TiBP-AMPA 
compared to 60% for TiBP-GL13K, the conservation of structure in the TiBP domain by the 
superimposed predicted secondary structures shown in Figure 3 suggests equal percentages 
of identity or relatedness for the binding domains. However, the analysis of backbone 
dynamics revealed that the antimicrobial domain of TiBP-AMPA was more highly ordered 
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than that of TiBP-GL13K. The expected disordered region represented by the TiBP in both 
bifunctional peptides extends through the spacer, and much of the antimicrobial domain is 
disordered for TiBP-GL13K. This finding could affect the anchoring of the bifunctional 
peptide on the disc, as the disordered region of GL13K may be more available to interact 
with the implant surface nonspecifically. Additionally, the proposed mechanism of 
antimicrobial function is more dependent on the hydrophobicity and amphipathicity of the 
peptide without the additional effects attributed to the increased stability and greater number 
of α-helical secondary structure features in the AMPA compared to Gl13K. Secondary 
structure modeling revealed that the AMPA domain comprised two α-helical features joined 
by a turn compared to only one α-helical feature for GL13K.
The hydrophobic ratio of TiBP-AMPA was slightly greater (30%) than that of TiBP-GL13K 
(26%). More hydrophobic residues were aligned on the same face of TiBP-AMPA, with 10 
residues being aligned for TiBP-AMPA compared to only 5 residues for TiBP-GL13K. With 
regard to hydrophobicity and amphipathicity, the design prediction based on the sequence 
and structure supported the experimental finding that TiBP-AMPA has greater antimicrobial 
activity than TiBP-Gl13K.
Overall, the antimicrobial peptide film property is observed to be dependent on the extent of 
the α-helical secondary structural features. Peptide stability under competitive binding 
environment was observed to be related to the ordered structures observed from our analysis 
of backbone dynamics. Molecular recognition based peptide self-assembly domain 
prevented removal of the peptide even under harsh washing conditions. Ordering seems to 
provide the TiBP-AMPA peptide a competitive advantage. It may be plausible to design 
TiBP-GL13K with a different spacer combination which would induce an ordering in the 
structure and enhance its competitive binding. Conformational design parameters are 
postulated to play a critical role in the peptide stability considering the anchoring domain of 
the bifunctional peptides are the same. Secondary structure may undergo major changes on 
the metal surfaces, however functional assembly behavior under the biologically challenged 
material interfaces may still have a folding preferential.
Taken together, our experimental results demonstrate that using computationally efficient, 
less resource intensive methods can be used to successfully predict the properties of 
bifunctional peptide prior to more costly and time-consuming experimental evaluation. The 
computational design approach was validated experimentally by assessing the binding and 
antimicrobial function of bifunctional peptides on a simulated implant surface. This 
technology and approach to design represents a novel strategy to improving and developing 
bifunctional peptide films to combat bacterial infection and prevent/treat peri-implant 
disease. Prior to clinical trials, the cytocompatibility and biocompatibility of the bifunctional 
peptides to human cells will need to be examined. Additionally, the incorporation of AMP 
sequences not previously explored as antimicrobial agents in bifunctional peptides 
represents an opportunity to develop more broad-spectrum antibacterial efficacy, as well as 
options for treatment of antibiotic resistant bacterial strains. The predictive design approach 
developed here offers a method for evaluating the functional efficacy of AMP, spacer, and 
binding domain combinations based on analyses of the relationship between sequence, 
structure and function. Combining this approach with the recently developed soft epitaxial 
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fit for the binding domain of the peptide to match the epitaxial sites on the implant surfaces 
would be another area to explore in order to tune the functionality at the solid-interface. This 
approach may also provide predictable-, rational-, peptide design approaches for a wide 
range of hybrid interfaces by combining conformational and interface design aspects 93.
CONCLUSION
We developed a predictive computational approach for designing bifunctional peptides that 
sought to correlate structure and function, e.g. antimicrobial activity and demonstrated that 
the resulting peptides show promise as a medicinal approach to addressing bacterial 
dysbiogenesis94–95 that leads to peri-implant disease with a shortening of the useful life of 
dental implants. With over 3 million implants placed in the US alone and growing by 
500,000 implants/year 7, a reduced service life ending in implant failure will adversely 
impact public health. The rapid (two minute) delivery of antimicrobial bifunctional peptide 
films was tested on dental implant surfaces mimicking the application sequence necessary 
for re-treatment of peri-implantitis in a dental office 63. The designed functional peptides 
consisted of three domains, from the N’-terminus: titanium binding, spacer and 
antimicrobial.
While the antimicrobial peptides were varied, the binding and spacer domains were kept 
constant with the goal of demonstrating that a computational approach can predict the 
antimicrobial properties of the resulting bifunctional peptide films. The percentage of α-
helicity of the bifunctional peptides and their individual constituting domains were 
computationally predicted by the Chou-Fasman algorithm. The peptides were further 
analyzed using chimera secondary structure models and these secondary structure 
predictions were compared experimentally using CD spectroscopy. This predictive design 
approach considered the structure and function of the entire bifunctional peptide molecule. 
Three design methods were used here, namely sequence-based, de novo modeling, and 
experimental evaluation; all indicated that peptide incorporating the AMPA anti-microbial 
domain had greater helical content than the one containing the GL13K antimicrobial 
domain. This prediction was confirmed by the backbone dynamic data. This ensemble of 
structural analysis techniques formed the basis for the prediction that TiBP-AMPA would 
functionally outperform TiBP-GL13K as an antimicrobial peptide film. In particular, 
amphipathie and α-helicity were shown to be more prominent in ordered regions, which 
contribute to greater antimicrobial peptide film activity. The bifunctional peptides were 
evaluated experimentally for their potential to prevent and treat peri-implant disease. The 
bifunctional peptides were delivered in the clinically relevant manner (2 minute binding 
period), under competition with serum proteins. Their mechanical durability was tested, and 
they were empirically challenged with bacteria to confirm our computational predictions. 
The peptide films have been shown capable of rebinding ability through up to five cycles of 
bacterial fouling, cleaning and reapplication. These results demonstrate the success of our 
computational design approach and suggest that the TiBP-AMPA peptide has strong 
potential as a treatment for peri-implant disease due to its ability mitigate bacterial biofilm 
formation.
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Figure 1: Helical wheel predictions of bifunctional peptides.
Hydrophilic amino acid residues are represented as circles, hydrophobic amino acid residues 
as diamonds, potentially negatively charged residues as triangles, and potentially positively 
charged residues as pentagons. The most hydrophobic amino acid residue is shown in green 
with the chroma intensity decreasing proportionally to hydrophobicity, with zero 
hydrophobicity coded as yellow. Hydrophilic residues are coded red, with intense red 
chroma being the most hydrophilic (uncharged) residue, and the chroma decreasing 
proportionally to the hydrophilicity. Potentially charged residues are shown as blue.
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Figure 2: DynaMine classification for backbone dynamics of amino acids comprising each 
bifunctional peptide.
The AMP domains located on the C’-terminus represent a more ordered region relative to 
the TiBP binding domain located on the N’-terminus. The TiBP domain is an intrinsically 
disordered peptide. AMPA has more order than GL13K, which could contribute to its greater 
predicted antimicrobial function.
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Figure 3: Secondary structure models and structural similarity analysis.
Each TiBP domain is colored purple, the AMPA domain is colored orange, the GL13K 
domain is colored red, and the spacer domain linking the antimicrobial and binding domain 
is colored black. The chart depicts the structural similarity determined by superimposing the 
domain model over the bifunctional model and calculating the percent identity.
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Figure 4: Theoretical and experimental CD spectra with deconvolution using Beta Sheet 
Selection (BeStSel).
Experimental CD spectra were collected in aqueous environment and with increasing 
concentrations of 2,2,2-trifluoroethanol. The pie charts represent BeStSel’s deconvolution of 
the CD spectra.
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Figure 5: Fluorescent microscopy images of bifunctional peptide binding to titanium implant 
discs, binding with competition from BSA, and durability following 1 minute of brushing with an 
electric toothbrush.
The chart depicts the means and standard deviations of three replicate experiments for each 
bifunctional peptide in each condition. TiBP-AMPA binding was statistically significant 
compared to binding in competition with BSA and durability after 1-minute of brushing (p < 
0.05). Statistical significance was determined for all conditions of TiBP-GL13K bifunctional 
peptide (p < 0.05). Statistical analysis was conducted using a one-way ANOVA.
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Visualization of FITC labeled bifunctional peptides using fluorescence microscopy after 
challenge by S. mutans for 24 hours. The percentage of peptide coverage was determined by 
evaluating images with a MATLAB script. The chart represents results obtained during three 
replicate experiments, of which, the fluorescence images are selected as representative of the 
whole. A statistically significant difference (p < 0.05) was found between the means for 
TiBP-AMPA and TiBP-GL13K coverage using a one-way ANOVA.
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Figure 7: Fluorescence microscopy images and quantification of propidium iodide (PI) staining 
of dead S. mutans bacteria on implant discs after challenge for 24 hours.
Dead bacteria appear with red fluorescence. The means and standard deviations are depicted 
in the chart for bare, sterilized titanium discs and discs functionalized by 2 minutes of 
bifunctional peptide binding at 37°C prior to bacterial challenge. Three replicate 
experiments were performed and a statistically significant difference (p < 0.05) was 
observed between means using ANOVA.
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Our approach includes an antimicrobial peptide film based upon an engineered bifunctional 
peptide composed of peptide domains for implant binding and antimicrobial activity 
separated by a spacer. The peptide was tested using a variety of in vitro assays to 
demonstrate its suitability.
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Table 1:
Chou-Fasman secondary structure predictions from amino acid sequences for the 
bifunctional peptide and its constitutive domains.
Secondary structure features including helix (α, 310 and π-helix), beta (β-bridge, bonded turn), and irregular 
(bend and loop) features.
α-helix β-strand irregular
TiBP 0% 0% 100%
AMPA 60% 0% 40%
GL13K 0% 0% 100%
TiBP-AMPA 69% 0% 31%
TiBP-GL13K 50% 0% 50%
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Table 2:
Physicochemical properties of peptides.
# AA MW pI Charge GRAVY
TiBP RPRENRGRERGL 12 1496 12 +3 −2.6
AMPA KWKLWKKIEKWGQGIGAVLKWLTTW 25 3085 10 +5 −0.4
GL13K GKIIKLKASLKLL 13 1429 11 +4 0.7
TiBP-AMPA RPRENRGRERGL GSGGG KWKLWKKIEKWGQGIGAVLKWLTTW 43 4991 12 +8 −1
TiBP-GL13K RPRENRGRERGL GSGGGG KIIKLKASLKLL 30 3218 12 +7 −0.8
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Table 3:
Theoretical “footprint” calculation and concentrations.
Theoretical Footprint Conc.
Length (Å) Width (Å) Area (Å2) μM
TiBP-AMPA 19.8 16.6 329 111
T1BP-GL13K 14.7 11.8 173 211
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